This blog category covers the application of Design of Experiments (DOE) within the pharmaceutical industry, specifically focusing on EnerTherm Engineering’s GMP-validated methodology for process optimization and regulatory compliance. Content should explore the implementation of the 8-step framework—Planning, Screening, Modelling, Optimisation, Verification, Execution, Analysis, and Utilisation—to solve complex formulation and manufacturing challenges. Articles should detail how these statistical methods replace traditional one-factor-at-a-time testing to achieve a 50% reduction in experimental requirements and 3x faster development cycles. Key technical topics include: Formulation Development (excipient/API interactions), Tablet Coating (spray rates, pan speeds, inlet temperatures), Dissolution Rate Analysis, and process optimization for granulation and lyophilization. Content must emphasize adherence to ICH Q8, Q9, and Q10 guidelines, ALCOA+ data integrity principles, and Quality by Design (QbD) strategies. Authors should discuss the use of specific statistical designs such as Fractional Factorial, Plackett-Burman, Definitive Screening, Central Composite, and Box-Behnken, as well as the integration of AI-driven techniques like neural networks (SANN) and machine learning to identify non-linear process relationships. Deliverables to be highlighted include experimental design reports, statistical analysis packages (ANOVA, response surface contour maps), predictive models, and the definition of Design Spaces for Critical Process Parameters (CPPs). All content must reflect EnerTherm’s focus on audit-ready GMP documentation, traceability, and the translation of statistical insights into actionable SOPs and control plans.